Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com